Search Results

4.Chronic hepatitis B virus infection, its treatment and prevention.

Hui ZHUANG

Chinese Journal of Hepatology 2005;13(5):324-325

5.Understanding immunopathogenic progresses of the hepatitis B virus provides insights into potential novel targets for antiviral therapy.

Ding-feng ZHANG

Chinese Journal of Hepatology 2012;20(1):71-74

6.The current progress of autoimmune hepatitis.

Xiao-di WANG

Chinese Journal of Hepatology 2004;12(1):58-60

7.Mechanism and treatment of hepatitis virus-related thrombocytopenia.

Zhaoyue WANG

Chinese Journal of Hematology 2014;35(7):667-669

8.Clinical characteristics and psychotropic therapy of depression and anxious symptoms of patients with HBV infection.

Xiaorong ZHANG ; Ge WANG ; Lu HU ; Jun WANG ; Dongfeng CHEN

Chinese Journal of Hepatology 2002;10(3):192-192

9.Occurrence and recurrence of hepatitis C-related hepatocellular carcinoma after direct antiviral treatment.

Yu Qing YANG ; Xiao Yuan XU

Chinese Journal of Hepatology 2022;30(1):103-106

Hepatitis C virus (HCV) RNA can be cleared from the blood circulation by direct antiviral treatment to achieve sustained virologic response (SVR). Studies have shown that SVR after direct antiviral therapy can reduce the incidence of hepatocellular carcinoma; however, monitoring for hepatocellular carcinoma is still needed. This review briefly summarizes and discusses the existing studies on the possible causes of hepatitis C secondary to HCC after antiviral therapy, which is mainly divided into epigenetic alterations and abnormal DNA methylation, HCV-related cirrhosis and abnormal DNA amplification, HBV reactivation, several aspects of occult HCV infection, and the effect of direct antiviral treatment on hepatocellular carcinoma recurrence. In few cases, direct antiviral treatment cannot completely prevent the occurrence and recurrence of hepatitis C-related hepatocellular carcinoma. Therefore, its mechanism needs to be studied and explored, and clinicians should also approach it with caution.
Antiviral Agents/therapeutic use* ; Carcinoma, Hepatocellular/drug therapy* ; Hepatitis C/drug therapy* ; Hepatitis C, Chronic/drug therapy* ; Humans ; Liver Neoplasms/etiology* ; Sustained Virologic Response

10.Portal flow steal after liver transplantation.

Bohyun KIM ; Kyoung Won KIM ; Gi Won SONG ; Sung Gyu LEE

Clinical and Molecular Hepatology 2015;21(3):314-317

1.Diagnosis and management of autoimmune hepatitis with acute presentation.

2.The relevant factors and principles of therapy to relapse chronic hepatitis C.

3.Antiviral treatment of kidney transplant patients with hepatitis C recurrence: a case report.